Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome?

被引:17
|
作者
Voykov, Bogomil [1 ]
Deuter, Christoph [1 ]
Zierhut, Manfred [1 ]
Leitritz, Martin Alexander [1 ]
Guenova-Hoetzenecker, Emmanuella [2 ]
Doycheva, Deshka [1 ,3 ]
机构
[1] Univ Hosp Tubingen, Ctr Ophthalmol, D-72076 Tubingen, Germany
[2] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[3] Knappschaft Eye Hosp, Sulzbach, Germany
关键词
Fuchs' uveitis syndrome; Uveitic glaucoma; Intraocular pressure; Cyclophotocoagulation; DIODE-LASER CYCLOPHOTOCOAGULATION; INTRAOCULAR-LENS IMPLANTATION; HETEROCHROMIC IRIDOCYCLITIS; REFRACTORY GLAUCOMA; DEEP SCLERECTOMY; TRANSSCLERAL CYCLOPHOTOCOAGULATION; OUTCOMES; TRABECULECTOMY; PHACOEMULSIFICATION; TRABECULOPLASTY;
D O I
10.1007/s00417-013-2558-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Glaucoma is one of the sight-threatening complications of Fuchs' uveitis syndrome (FUS) and the most difficult to manage. The goal of this study was to assess the efficacy and safety of cyclophotocoagulation (CPC) in the management of glaucoma secondary to FUS. In a retrospective analysis, the charts of all patients with FUS referred to our clinic from January 2002 to December 2012 were reviewed. In patients with glaucoma or ocular hypertension, controlled eye pressure was defined using two alternative upper limits of 6 a parts per thousand currency signaEuro parts per thousand IOP a parts per thousand currency signaEuro parts per thousand 21 mmHg and 6 a parts per thousand currency signaEuro parts per thousand IOP a parts per thousand currency signaEuro parts per thousand 18 mmHg at 1 year follow-up. One hundred and seventy-six patients with FUS were included in this study. Of those, 28 had ocular hypertension (OHT) or glaucoma. Mean maximal intraocular pressure (IOP) of patients with glaucoma/OHT was 40.8 mmHg. Twenty-three patients (82.1 %) had maximal IOP levels of 35 mmHg or higher. Sixteen patients with glaucoma/OHT underwent CPC alone (ten patients) or in combination with other surgical procedures (six patients). After 1 year, control of IOP for both upper limits (6 a parts per thousand currency signaEuro parts per thousand IOP a parts per thousand currency signaEuro parts per thousand 18 mmHg) and (6 a parts per thousand currency signaEuro parts per thousand IOP a parts per thousand currency signaEuro parts per thousand 21 mmHg) was achieved in six of ten patients (60 %) who received CPC alone, and in five of six patients (83.3 %) who required additional surgery after CPC. The mean number of cycloablative procedures was 1.3 (range 1-2) in the CPC alone group and 1.2 (range 1-2) in patients for whom CPC was used as adjunct therapy. There was no exacerbation of intraocular inflammation, no postoperative hypotony and no phthisis bulbi in the 16 patients who underwent CPC. CPC is a safe and effective procedure that should be considered if medical treatment has failed to control glaucoma in FUS.
引用
收藏
页码:485 / 489
页数:5
相关论文
共 50 条
  • [1] Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs’ uveitis syndrome?
    Bogomil Voykov
    Christoph Deuter
    Manfred Zierhut
    Martin Alexander Leitritz
    Emmanuella Guenova-Hötzenecker
    Deshka Doycheva
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 485 - 489
  • [2] Erratum to: Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs’ uveitis syndrome?
    Bogomil Voykov
    Christoph Deuter
    Manfred Zierhut
    Martin Alexander Leitritz
    Emmanuella Guenova
    Deshka Doycheva
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 1023 - 1023
  • [3] Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome? (vol 252, pg 485, 2014)
    Voykov, Bogomil
    Deuter, Christoph
    Zierhut, Manfred
    Leitritz, Martin Alexander
    Guenova, Emmanuella
    Doycheva, Deshka
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 1023 - 1023
  • [4] Outcomes of Ahmed Glaucoma Valve Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome
    Voykov, Bogomil
    Doycheva, Deshka
    Deuter, Christoph
    Leitritz, Martin Alexander
    Dimopoulos, Spyridon
    William, Antony
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (06) : 760 - 766
  • [5] Surgical management of glaucoma in Fuchs uveitis syndrome: Trabeculectomy or Ahmed glaucoma valve
    Nilforushan, Naveed
    Yadgari, Maryam
    Alemzadeh, Sayyed Amirpooya
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2019, 31 (01): : 24 - 30
  • [6] Aqueous humour cytokines in Fuchs uveitis syndrome patients with or without secondary glaucoma
    Heinz, Carsten
    Kasper, Maren
    Tektas, Ozan
    Bauer, Dirk
    Walscheid, Karoline
    Koch, Joerg
    Muether, Philipp
    Heiligenhaus, Arnd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [7] XEN45 Gelstent Implantation in the Treatment of Glaucoma Secondary to Fuchs Uveitis Syndrome
    Faber, Hanna
    Guggenberger, Vanessa
    Voykov, Bogomil
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (7-8) : 1678 - 1685
  • [8] Transscleral cyclophotocoagulation as primary management in a nanophthalmic eye with anterior uveitis and secondary mixed mechanism glaucoma
    Bromeo, Albert John
    Bartilad, Kathrin
    BMJ CASE REPORTS, 2019, 12 (12)
  • [9] Gonioscopy-assisted transluminal trabeculotomy as a primary surgical option for glaucoma in Fuchs uveitis syndrome: A case series
    Gunay, Murat
    Turk, Adem
    Kurt, Ibrahim Mert
    Uzlu, Dilek
    Kose, Busra
    Yildirim, Yusuf
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (05) : NP16 - NP21
  • [10] Management of secondary glaucoma in patients with uveitis
    Mumcuoglu, T.
    Ozge, G.
    ACTA OPHTHALMOLOGICA, 2014, 92